Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Amer M. Zeidan; Pierre Fenaux; Marco Gobbi; Jiří Mayer; Gail J. Roboz; Jürgen Krauter; Tadeusz Robak; Hagop M. Kantarjian; Jan Novák; Wieslaw W. Jedrzejczak; Xavier Thomas; Mario Ojeda-Uribe; Yasushi Miyazaki; Yoo Hong Min; Su Peng Yeh; Joseph M. Brandwein; Liana Gercheva; Judit Demeter; Elizabeth A. Griffiths; Karen W.L. Yee; Jean Pierre J. Issa; Jan Philipp Bewersdorf; Harold Keer; Yong Hao; Mohammad Azab; Hartmut Döhner

doi:10.1182/blood.2022015832

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Amer M. Zeidan
, Pierre Fenaux
, Marco Gobbi
, Jiří Mayer
, Gail J. Roboz
, Jürgen Krauter
, Tadeusz Robak
, Hagop M. Kantarjian
, Jan Novák
, Wieslaw W. Jedrzejczak
, Xavier Thomas
, Mario Ojeda-Uribe
, Yasushi Miyazaki
, Yoo Hong Min
, Su Peng Yeh
, Joseph M. Brandwein
, Liana Gercheva
, Judit Demeter
, Elizabeth A. Griffiths
, Karen W.L. Yee

Jean Pierre J. Issa, Jan Philipp Bewersdorf, Harold Keer, Yong Hao, Mohammad Azab, Hartmut Döhner

Office of Research Compliance

Yale University
Université Paris Cité
Ospedale Policlino San Martino -University of Genoa
Masaryk University
Cornell University
New York Presbyterian Hospital
Städtisches Klinikum Braunschweig gGmbH
Medical University of Łódź
University of Texas MD Anderson Cancer Center
Charles University
Medical University of Warsaw
Hospices civils de Lyon
Groupe Hospitalier de la Région Mulhouse Sud-Alsace
Nagasaki University
Yonsei University
China Medical University Taichung
University of Alberta
Multiprofile Hospital for Active Treatment Sveta Marina EAD
Semmelweis University
University Health Network
Coriell Institute for Medical Research
Memorial Sloan-Kettering Cancer Center
Astex Pharmaceuticals
Ulm University

Research output: Contribution to journal › Letter › peer-review

34 Scopus citations

Original language	English
Pages (from-to)	285-289
Number of pages	5
Journal	Blood
Volume	140
Issue number	3
DOIs	https://doi.org/10.1182/blood.2022015832
State	Published - Jul 21 2022

Access to Document

10.1182/blood.2022015832

Cite this

Zeidan, A. M., Fenaux, P., Gobbi, M., Mayer, J., Roboz, G. J., Krauter, J., Robak, T., Kantarjian, H. M., Novák, J., Jedrzejczak, W. W., Thomas, X., Ojeda-Uribe, M., Miyazaki, Y., Min, Y. H., Yeh, S. P., Brandwein, J. M., Gercheva, L., Demeter, J., Griffiths, E. A., ... Döhner, H. (2022). Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy. Blood, 140(3), 285-289. https://doi.org/10.1182/blood.2022015832

@article{8703b27b30a44ebd999e447e636912d8,

title = "Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy",

author = "Zeidan, \{Amer M.\} and Pierre Fenaux and Marco Gobbi and Ji{\v r}{\'i} Mayer and Roboz, \{Gail J.\} and J{\"u}rgen Krauter and Tadeusz Robak and Kantarjian, \{Hagop M.\} and Jan Nov{\'a}k and Jedrzejczak, \{Wieslaw W.\} and Xavier Thomas and Mario Ojeda-Uribe and Yasushi Miyazaki and Min, \{Yoo Hong\} and Yeh, \{Su Peng\} and Brandwein, \{Joseph M.\} and Liana Gercheva and Judit Demeter and Griffiths, \{Elizabeth A.\} and Yee, \{Karen W.L.\} and Issa, \{Jean Pierre J.\} and Bewersdorf, \{Jan Philipp\} and Harold Keer and Yong Hao and Mohammad Azab and Hartmut D{\"o}hner",

year = "2022",

month = jul,

day = "21",

doi = "10.1182/blood.2022015832",

language = "English",

volume = "140",

pages = "285--289",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "3",

}

Zeidan, AM, Fenaux, P, Gobbi, M, Mayer, J, Roboz, GJ, Krauter, J, Robak, T, Kantarjian, HM, Novák, J, Jedrzejczak, WW, Thomas, X, Ojeda-Uribe, M, Miyazaki, Y, Min, YH, Yeh, SP, Brandwein, JM, Gercheva, L, Demeter, J, Griffiths, EA, Yee, KWL, Issa, JPJ, Bewersdorf, JP, Keer, H, Hao, Y, Azab, M & Döhner, H 2022, 'Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy', Blood, vol. 140, no. 3, pp. 285-289. https://doi.org/10.1182/blood.2022015832

TY - JOUR

T1 - Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

AU - Zeidan, Amer M.

AU - Fenaux, Pierre

AU - Gobbi, Marco

AU - Mayer, Jiří

AU - Roboz, Gail J.

AU - Krauter, Jürgen

AU - Robak, Tadeusz

AU - Kantarjian, Hagop M.

AU - Novák, Jan

AU - Jedrzejczak, Wieslaw W.

AU - Thomas, Xavier

AU - Ojeda-Uribe, Mario

AU - Miyazaki, Yasushi

AU - Min, Yoo Hong

AU - Yeh, Su Peng

AU - Brandwein, Joseph M.

AU - Gercheva, Liana

AU - Demeter, Judit

AU - Griffiths, Elizabeth A.

AU - Yee, Karen W.L.

AU - Issa, Jean Pierre J.

AU - Bewersdorf, Jan Philipp

AU - Keer, Harold

AU - Hao, Yong

AU - Azab, Mohammad

AU - Döhner, Hartmut

PY - 2022/7/21

Y1 - 2022/7/21

UR - https://www.scopus.com/pages/publications/85134777585

U2 - 10.1182/blood.2022015832

DO - 10.1182/blood.2022015832

M3 - Letter

C2 - 35507690

AN - SCOPUS:85134777585

SN - 0006-4971

VL - 140

SP - 285

EP - 289

JO - Blood

JF - Blood

IS - 3

ER -

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Access to Document

Other files and links

Fingerprint

Cite this